A highly efficient hybrid peptide ameliorates intestinal inflammation and mucosal barrier damage by neutralizing lipopolysaccharides and antagonizing the lipopolysaccharide‐receptor interaction-Reference-Cited by-同舟云学术

A highly efficient hybrid peptide ameliorates intestinal inflammation and mucosal barrier damage by neutralizing lipopolysaccharides and antagonizing the lipopolysaccharide‐receptor interaction

Published:2020-10-15 Issue:12 Volume:34 Page:16049-16072
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Wei Xubiao¹,Zhang Lulu¹,Zhang Rijun¹,Wu Rujuan¹,Si Dayong¹,Ahmad Baseer¹,Petitte James N.²,Mozdziak Paul E.²,Li Zhongxuan¹,Guo Henan¹,Zhang Manyi¹

Affiliation:

1. State Key Laboratory of Animal Nutrition College of Animal Science and Technology China Agricultural University Beijing China

2. College of Agriculture and Life Sciences North Carolina State University Raleigh NC USA

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.201903263RRR

Reference115 articles.

1. Picrasma quassioides inhibits LPS- and IFN-γ-stimulated nitric oxide production and inflammatory response in RAW264.7 macrophage cells

2. Synthetic high-density lipoprotein-like nanoparticles potently inhibit cell signaling and production of inflammatory mediators induced by lipopolysaccharide binding Toll-like receptor 4

3. Origin and physiological roles of inflammation

4. The role of oxidative stress, antioxidants and vascular inflammation in cardiovascular disease (a review)

5. Inflammation and cancer: back to Virchow?

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combating bacterial infections with host defense peptides: Shifting focus from bacteria to host immunity;Drug Resistance Updates;2024-01

2. Exploring the microscopic terrain of the small intestinal epithelium: a comprehensive overview of general architecture and the present understanding of intestinal stem cells;Medical Journal of Cell Biology;2023-12-01

3. The transcription factor ELF4 alleviates inflammatory bowel disease by activating IL1RN transcription, suppressing inflammatory TH17 cell activity, and inducing macrophage M2 polarization;Frontiers in Immunology;2023-11-06

4. Mechanisms of action of anti-inflammatory proteins and peptides with anti-TNF-alpha activity and their effects on the intestinal barrier: A systematic review;PLOS ONE;2022-08-08

5. A novel ladderlectin from hybrid crucian carp possesses antimicrobial activity and protects intestinal mucosal barrier against Aeromonas hydrophila infection;Fish & Shellfish Immunology;2022-05